Effect Analysis of Recombinant Human Interferon a1b Nebulized Inhalation in Treatment of Bronchiolitis
Objective To study value and effect of recombinant human interferon a1b nebulized inhalation therapy for bronchiolitis.Methods The paper divided 50 children with bronchiolitis from November 2022 and October 2023 with random number table method,with 25 cases in each group.Reference group was treated with routine treatment,while experimental group with nebulized inhalation of recombinant human interferon a1b on the basis of routine treatment.Lung ventilation function,inflammatory indicators,clinical symptom disappearance time,length of stay,and clinical treatment effect were statistically verified between two groups.Results RR of experimental group was lower than reference group,VT and VPEF/VE was higher than reference group,TNF-α,CRP and IL-6 was lower than control group,disappearance time and length of stay of clinical symptoms including wheezing,lung rales,and cough was shorter than control group.Clinical effect was better than control group,P＜0.05,indicating statistical difference between data indicators.Conclusion Recombinant human interferon a1b can quickly improve clinical symptoms of children with bronchiolitis,regulate lung ventilation function,reduce inflammatory reactions,and improve clinical curative effect effectively.
Recombinant human interferon a1bNebulization inhalationBronchiolitis
万方数据
维普
